publicaciones seleccionadas
-
artículo académico
- Neuroprotective Activity of 3-((6-(Phenylethynyl)pyridin-3- yl)oxy)quinuclidine: A Potential Ligand for the Treatment of Alzheimer's Disease. ACS CHEMICAL NEUROSCIENCE. 16(23):4502-4510. 2025
- Modulation of GABAA receptors and of GABAergic synapses by the natural alkaloid gelsemine. FRONTIERS IN MOLECULAR NEUROSCIENCE. 15. 2023
- Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-beta Peptide Toxicity. JOURNAL OF ALZHEIMERS DISEASE. 94:S97-S108. 2023
- TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease. BIOMEDICINE & PHARMACOTHERAPY. 162. 2023
- Changes in PGC-1 alpha/SIRT1 Signaling Impact on Mitochondrial Homeostasis in Amyloid-Beta Peptide Toxicity Model. FRONTIERS IN PHARMACOLOGY. 11. 2020
- 17 Oxo Sparteine and Lupanine, Obtained from Cytisus scoparius, Exert a Neuroprotection against Soluble Oligomers of Amyloid-beta Toxicity by Nicotinic Acetylcholine Receptors. JOURNAL OF ALZHEIMERS DISEASE. 67(1):343-356. 2019
- Exposure to UV-B Radiation Leads to Increased Deposition of Cell Wall-Associated Xerocomic Acid in Cultures of Serpula himantioides. APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 85(18):1-13. 2019
- A Natural Benzofuran from the Patagonic Aleurodiscus vitellinus Fungus has Potent Neuroprotective Properties on a Cellular Model of Amyloid-beta Peptide Toxicity. JOURNAL OF ALZHEIMERS DISEASE. 61(4):1463-1475. 2018
- P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of alzheimer´s disease. NEUROPHARMACOLOGY. 128:366-378. 2018